A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis
Status: Recruiting
Location: See all (40) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Adult subjects (18-75 years old)
• Diagnosis of non-infectious uveitis (intermediate uveitis, posterior uveitis, or panuveitis)
• Active uveitic disease in at least 1 eye
• Weight \> 40 kg with a body mass index ≤ 40 kg/m2
Locations
United States
Arizona
Clinical Trial Site
RECRUITING
Phoenix
California
Clinical Trial Site
RECRUITING
Bakersfield
Clinical Trial Site
RECRUITING
Beverly Hills
Clinical Trial Site
RECRUITING
Fullerton
Clinical Trial Site
RECRUITING
Irvine
Clinical Trial Site
RECRUITING
La Jolla
Clinical Trial Site
RECRUITING
Los Angeles
Clinical Trial Site
RECRUITING
Los Angeles
Clinical Trial Site
RECRUITING
Modesto
Clinical Trial Site
RECRUITING
Sacramento
Colorado
Clinical Trial Site
RECRUITING
Aurora
Florida
Clinical Trial Site
RECRUITING
Fort Lauderdale
Clinical Trial Site
RECRUITING
St. Petersburg
Indiana
Clinical Trial Site
RECRUITING
Carmel
Massachusetts
Clinical Trial Site
RECRUITING
Boston
Clinical Trial Site
RECRUITING
Waltham
Michigan
Clinical Trial Site
RECRUITING
Ann Arbor
Clinical Trial Site
RECRUITING
Detroit
Minnesota
Clinical Trial Site
RECRUITING
Minneapolis
Clinical Trial Site
RECRUITING
Rochester
Missouri
Clinical Trial Site
RECRUITING
St Louis
North Carolina
Clinical Trial Site
RECRUITING
Durham
Nebraska
Clinical Trial Site
RECRUITING
Omaha
New Jersey
Clinical Trial Site
RECRUITING
Palisades Park
New York
NYU Langone Health
RECRUITING
New York
Ohio
Clinical Trial Site
RECRUITING
Cleveland
Oregon
Clinical Trial Site
RECRUITING
Portland
Clinical Trial Site
RECRUITING
Portland
Pennsylvania
Clinical Trial Site
RECRUITING
Erie
Clinical Trial Site
RECRUITING
Philadelphia
Clinical Trial Site
RECRUITING
Philadelphia
Tennessee
Clinical Trial Site
RECRUITING
Nashville
Texas
Clinical Trial Site
RECRUITING
Austin
Clinical Trial Site
RECRUITING
Bellaire
Clinical Trial Site
RECRUITING
Dallas
Clinical Trial Site
RECRUITING
Houston
Clinical Trial Site
RECRUITING
Katy
Clinical Trial Site
RECRUITING
Plano
Clinical Trial Site
RECRUITING
Round Rock
Wisconsin
Clinical Trial Site
RECRUITING
Madison
Contact Information
Primary
Clinical Trial Administrator
clinicaltrials@priovanttx.com
(212) 634-9743
Time Frame
Start Date: 2024-09-11
Estimated Completion Date: 2028-02-01
Participants
Target number of participants: 300
Treatments
Experimental: Arm 1
Placebo_comparator: Arm 2
Related Therapeutic Areas
Sponsors
Leads: Priovant Therapeutics, Inc.